Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares RepurchasedShort-Term Debt repayments
Ratios

Bio-Techne (TECH) Short-Term Debt repayments (2016 - 2025)

Historic Short-Term Debt repayments for Bio-Techne (TECH) over the last 12 years, with Q4 2025 value amounting to $40.0 million.

  • Bio-Techne's Short-Term Debt repayments changed N/A to $40.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $144.0 million, marking a year-over-year decrease of 204.08%. This contributed to the annual value of $77.0 million for FY2025, which is 6992.19% down from last year.
  • According to the latest figures from Q4 2025, Bio-Techne's Short-Term Debt repayments is $40.0 million.
  • Bio-Techne's 5-year Short-Term Debt repayments high stood at $441.0 million for Q3 2022, and its period low was $3.1 million during Q2 2022.
  • Moreover, its 5-year median value for Short-Term Debt repayments was $54.6 million (2021), whereas its average is $70.4 million.
  • Over the last 5 years, Bio-Techne's Short-Term Debt repayments had its largest YoY gain of 76259.17% in 2022, and its largest YoY loss of 9759.85% in 2022.
  • Bio-Techne's Short-Term Debt repayments (Quarter) stood at $58.1 million in 2021, then rose by 11.24% to $64.7 million in 2022, then fell by 10.3% to $58.0 million in 2023, then crashed by 67.24% to $19.0 million in 2024, then soared by 110.53% to $40.0 million in 2025.
  • Its last three reported values are $40.0 million in Q4 2025, $46.0 million for Q3 2025, and $50.0 million during Q2 2025.